These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33175616)

  • 21. Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate.
    Zhao JH; Zhang WF; Zhao YF
    Int J Oral Maxillofac Surg; 2004 Jul; 33(5):463-6. PubMed ID: 15183410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.
    Shigematsu T; Sorscher M; Dier EC; Berenstein A
    J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous sclerotherapy of para-orbital and orbital venous malformation: A single center, case series.
    Ahmad S; Akhtar FK
    Phlebology; 2019 Jun; 34(5):355-361. PubMed ID: 30336759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bleomycin Electrosclerotherapy Treatment in the Management of Vascular Malformations.
    Kostusiak M; Murugan S; Muir T
    Dermatol Surg; 2022 Jan; 48(1):67-71. PubMed ID: 34608081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.
    Bai Y; Jia J; Huang XX; Alsharif MJ; Zhao JH; Zhao YF
    J Oral Maxillofac Surg; 2009 Feb; 67(2):251-6. PubMed ID: 19138596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerotherapy for low-flow vascular malformations of the orbital and periocular regions: Systematic review and meta-analysis.
    De Maria L; De Sanctis P; Tollefson M; Mardini S; Garrity JA; Morris PP; Bendel E; Brinjikji W
    Surv Ophthalmol; 2020; 65(1):41-47. PubMed ID: 31425703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes.
    Dave TV; Madhuri BK; Laghmisetty S; Tripathy D; Kaliki S; Rath S; Mohapatra S; Desai A; Kapoor AG
    Eye (Lond); 2022 Apr; 36(4):789-799. PubMed ID: 33879854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous hyperpigmentation following bleomycin sclerotherapy for vascular malformations.
    Davis KP; Gaffey MM; Kompelli AR; Richter GT
    Pediatr Dermatol; 2022 Jan; 39(1):103-106. PubMed ID: 34897790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluoroscopic intralesional injection with pingyangmycin lipiodol emulsion for the treatment of orbital venous malformations.
    Chen Y; Li Y; Zhu Q; Zeng Q; Zhao J; He X; Mei Q
    AJR Am J Roentgenol; 2008 Apr; 190(4):966-71. PubMed ID: 18356443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular treatment of slow-flow vascular malformations.
    Burrows PE
    Tech Vasc Interv Radiol; 2013 Mar; 16(1):12-21. PubMed ID: 23499128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.
    Bothra N; Panda L; Sheth J; Tripathy D
    Eye (Lond); 2018 Jan; 32(1):152-155. PubMed ID: 28776595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicoradiologic predictors of sclerotherapy response in low-flow vascular malformations.
    Bagga B; Goyal A; Das A; Bhalla AS; Kandasamy D; Singhal M; Kairo A
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):209-219.e2. PubMed ID: 32653406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement.
    Horbach SER; van de Ven JS; Nieuwkerk PT; Spuls PI; van der Horst CMAM; Reekers JA
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1494-1504. PubMed ID: 29948003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralesional Bleomycin for Orbital Lymphatic Malformations: Comparison of Clinical Versus Radiologic Regression by Volumetric Analysis.
    Dave TV; Madhuri BK; Kaliki S
    Ophthalmic Plast Reconstr Surg; 2021 May-Jun 01; 37(3S):S85-S91. PubMed ID: 32976330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term side effects and patient-reported outcomes of bleomycin sclerotherapy in vascular malformations.
    Mack JM; Richter GT; Becton D; Salem O; Hill SEM; Crary SE
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27008. PubMed ID: 29431255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN; Nag U; Shortell CK
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of Distensible Orbital Venous-dominant Venolymphatic Malformations After Sclerotherapy Versus Embolization With Excision.
    Cohen LM; Goldberg RA; Rootman DB
    Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):283-288. PubMed ID: 34798656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.
    Chen WL; Huang ZQ; Zhang DM; Chai Q
    Head Neck; 2010 Apr; 32(4):467-72. PubMed ID: 19672870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.